Author

Jennifer Daw

University of New Mexico Health Sciences Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexander Goss· 1 shared Daisy Belmares-Ortega· 1 shared Geneva L. WilliamsiD· 1 shared Jamie L. Padilla· 1 shared Josh K. Monts· 1 shared Jun‐yong Choe· 1 shared Kimberly Kay LeslieiD· 1 shared Lane E. Smith· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexander Goss

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The novel curcumin analogue AKT-100 targets both mutant p53 and STAT3 in gynecologic cancer cells

Geneva L. Williams, Lane E. Smith, Jamie L. Padilla, Alexander Goss, Daisy Belmares-Ortega, Xiangxiang Wu, Jennifer Daw, Sumegha Mitra, Prakash G. Jagtap, Josh K. Monts, Jun‐yong Choe, Kimberly Kay Leslie

This paper develops AKT-100, a curcumin analogue that targets mutant p53 and STAT3 in gynecologic cancer cells, showing cytotoxicity and synergy with existing therapies.

bioRxiv · Oct 6, 2025 · PreprintCancer Biology